PubRank

Richard D Cannon

Author PubWeight™ 36.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell 2007 1.35
2 ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 2008 1.30
3 Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci U S A 2014 1.23
4 Sixty alleles of the ALS7 open reading frame in Candida albicans: ALS7 is a hypermutable contingency locus. Genome Res 2003 1.23
5 Antifungal drug resistance of oral fungi. Odontology 2010 1.21
6 Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol Microbiol 2006 1.16
7 Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J Antimicrob Chemother 2004 1.08
8 Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. Anal Biochem 2009 1.08
9 Candida glabrata ATP-binding cassette transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties. J Biol Chem 2002 1.05
10 Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrob Agents Chemother 2008 1.01
11 Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J Chromatogr B Analyt Technol Biomed Life Sci 2002 1.00
12 Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother 2005 1.00
13 Phosphorylation of candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability. J Biol Chem 2004 0.99
14 Fungal PDR transporters: Phylogeny, topology, motifs and function. Fungal Genet Biol 2009 0.98
15 The metabolic basis of Candida albicans morphogenesis and quorum sensing. Fungal Genet Biol 2011 0.93
16 Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor. Mol Microbiol 2012 0.91
17 The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Antimicrob Agents Chemother 2011 0.90
18 Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function. Mol Microbiol 2011 0.89
19 Use of denaturing gradient gel electrophoresis for the identification of mixed oral yeasts in human saliva. J Med Microbiol 2012 0.89
20 Characterization of the Saccharomyces cerevisiae sec6-4 mutation and tools to create S. cerevisiae strains containing the sec6-4 allele. Gene 2005 0.88
21 Insight into pleiotropic drug resistance ATP-binding cassette pump drug transport through mutagenesis of Cdr1p transmembrane domains. J Biol Chem 2013 0.87
22 A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model. FEMS Microbiol Lett 2012 0.87
23 Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae. Jpn J Infect Dis 2005 0.87
24 Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression. J Antimicrob Chemother 2012 0.86
25 Distribution of mutations distinguishing the most prevalent disease-causing Candida albicans genotype from other genotypes. Infect Genet Evol 2009 0.83
26 Impact of genetic background on allele selection in a highly mutable Candida albicans gene, PNG2. PLoS One 2010 0.83
27 Antifungal saponins from Paris polyphylla Smith. Planta Med 2008 0.82
28 Candida albicans binds to saliva proteins selectively adsorbed to silicone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 0.82
29 Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5. Mol Pharm 2014 0.81
30 N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis. Med Mycol 2011 0.80
31 Esthetic comparison of white-spot lesion treatment modalities using spectrometry and fluorescence. Angle Orthod 2013 0.80
32 The metabolic response of Candida albicans to farnesol under hyphae-inducing conditions. FEMS Yeast Res 2012 0.79
33 Genomic pathways to antifungal discovery. Curr Drug Targets Infect Disord 2002 0.78
34 Metabolic response of Candida albicans to phenylethyl alcohol under hyphae-inducing conditions. PLoS One 2013 0.78
35 Detection of Candida albicans mRNA in archival histopathology samples by reverse transcription-PCR. J Clin Microbiol 2004 0.77
36 Production from dairy cows of semi-industrial quantities of milk-protein concentrate (MPC) containing efficacious anti-Candida albicans IgA antibodies. J Dairy Res 2007 0.76
37 Small, synthetic, GC-rich mRNA stem-loop modules 5' proximal to the AUG start-codon predictably tune gene expression in yeast. Microb Cell Fact 2013 0.76
38 [ABC transporters of pathogenic fungi: recent advances in functional analyses]. Nihon Ishinkin Gakkai Zasshi 2005 0.76
39 Heterologous expression of Candida albicans Pma1p in Saccharomyces cerevisiae. FEMS Yeast Res 2013 0.75
40 Amino acid residues affecting drug pump function in Candida albicans--C. albicans drug pump function. Nihon Ishinkin Gakkai Zasshi 2006 0.75
41 Yeast colonization of voice prostheses: pilot study investigating effect of a bovine milk product containing anti-Candida albicans immunoglobulin A antibodies on yeast colonization and valve leakage. Ann Otol Rhinol Laryngol 2012 0.75
42 Antifungal drug susceptibilities of commensal Candida isolates. N Z Dent J 2002 0.75
43 Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps. Methods Mol Biol 2010 0.75
44 Erratum: Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric. Sci Rep 2016 0.75
45 Improving the effectiveness of chlorhexidine. N Z Dent J 2006 0.75
46 Response of human periodontal ligament cells to baicalin. J Periodontol 2014 0.75